|
TERF2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6251444634463E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.90119999638117E-08 |
| Normal-vs-Stage2 |
5.84299999999427E-05 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
8.567900E-04 |
| Stage1-vs-Stage2 |
9.295000E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
5.881200E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
6.099600E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.01538785660205E-12 |
| Normal-vs-AfricanAmerican |
4.04839994860851E-09 |
| Normal-vs-Asian |
3.64579999523329E-09 |
| Caucasian-vs-AfricanAmerican |
6.03020000045085E-07 |
| Caucasian-vs-Asian |
5.941400E-01 |
| AfricanAmerican-vs-Asian |
8.177500E-03 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.76100303415228E-11 |
| Normal-vs-Female |
5.86439996563826E-09 |
| Male-vs-Female |
8.802500E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.16069999994895E-06 |
| Normal-vs-Extreme_Weight |
2.59010000003279E-07 |
| Normal-vs-Obese |
9.999900E-04 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
3.754200E-01 |
| Normal_Weight-vs-Obese |
6.566600E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
7.221400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.754000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.21720003362935E-09 |
| Normal-vs-Age(61-80Yrs) |
1.97549999692015E-08 |
| Normal-vs-Age(81-100Yrs) |
1.4172000000201E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.785600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.658200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.279400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.703000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.479380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.039200E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
5.392800E-01 |
| Normal-vs-Grade 3 |
2.719000E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
2.893600E-01 |
| Grade 2-vs-Grade 4 |
5.392800E-01 |
| Grade 3-vs-Grade 4 |
2.719000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.54050114278925E-11 |
| Normal-vs-N1 |
1.054460E-02 |
| N0-vs-N1 |
7.923000E-01 |
|
|
